how many americans take glp-1 drugs America's Most Talked-About Drug Has a Surprising Secret: 69% of Users Are Unlikely to Admit Taking It Map Shows States Where Weight

What to Expect During the Process While GLP-1 treatments can lead to significant weight loss, its important to approach this journey with realistic expectations and proper guidance

Two CVOTs of tirzepatide are being conducted: SURPASS-CVOT (NCT04255433), which is targeting individuals with T2D and a history of CVD

While technologies such as permeation enhancers and nanoparticle-based systems have shown potential, their successful clinical translation remains constrained by challenges related to safety, scalability, and consistency

GLP-1 Receptor Agonists for Type 2 Diabetes | UK Guide Glucagon-like peptide-1 receptor agonists for type 2 diabetes are a class of injectable and oral medicines that help manage blood glucose levels in adults